Filing Details

Accession Number:
0001209191-21-009765
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-11 17:08:17
Reporting Period:
2021-02-09
Accepted Time:
2021-02-11 17:08:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1653087 Alector Inc. ALEC Biological Products, (No Disgnostic Substances) (2836) 462702363
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757964 Robert Paul C/O Alector, Inc.
131 Oyster Point Blvd, Suite 600
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-09 17,091 $8.16 230,810 No 4 M Direct
Common Stock Acquisiton 2021-02-09 2,084 $10.14 232,894 No 4 M Direct
Common Stock Disposition 2021-02-09 19,175 $20.81 213,719 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-02-09 17,091 $0.00 17,091 $8.16
Common Stock Employee Stock Option (right to buy) Disposition 2021-02-09 2,084 $0.00 2,084 $10.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
217,450 2028-07-02 No 4 M Direct
60,417 2028-11-06 No 4 M Direct
Footnotes
  1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.45 to $21.05, inclusive.
  3. One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter.
  4. One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter.